Clinical Trial Update: Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR) [Phase 4]

View source ↗

Summary

Phase 4 trial update on inflammation and thrombosis in patients with severe aortic stenosis after transcatheter aortic valve replacement (TAVR).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Aortic Stenosis, Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2022-07-20